PubMed COVID-19 Clinical Care

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

Development of an integrated sample amplification control for salivary point-of-care pathogen testing

Friday, January 05, 2024 - 4:00 AM

BACKGROUND: The COVID-19 pandemic has led to a rise in point-of-care (POC) and home-based tests, but concerns over usability, accuracy, and effectiveness have arisen. The incorporation of internal amplification controls (IACs), essential control for

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults

Friday, January 05, 2024 - 4:00 AM

This study used repeat serologic testing to estimate infection rates and risk factors in two overlapping cohorts of SARS-CoV-2 N protein seronegative U.S. adults. One mostly unvaccinated sub-cohort was tracked from April 2020 to March 2021 (pre